Penn Medicine study reveals inequities in access to transformative CAR T cell therapy

CAR T cell therapy is a personalized form of cancer therapy that was pioneered at Penn Medicine and has brought ... like this becomes available, it reaches all patients who might be able to ... Read More

Penn-pioneered cancer treatment shows promising results in treating brain cancer in new study

CAR-T cell therapy — a cancer treatment pioneered at Penn — has recently ... they are especially difficult to treat. In a Penn Medicine news release, Bagley said that glioblastomas “can evade a ... Read More

Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing

For patients with certain types of cancer, CAR T cell therapy has been nothing short of life changing. Developed in part by Carl June, Richard W. Vague Professor at Penn Medicine, and approved by ... Read More

Carl June, first year Emily Whitehead reflect on experiences with Penn-pioneered cancer treatment

Researcher Carl June led the Penn Medicine team that first used CAR-T cell therapy — a Penn-pioneered cancer treatment — to treat adult leukemia patients in 2010. In 2012, Emily Whitehead was the ... Read More

Equity in Healthcare: Addressing Disparities in CAR T-Cell Therapy Access for Minority Patients with Large B-Cell Lymphomas

A recent study published in NEJM Evidence suggests that minority patients may not have equal access to CAR T-cell therapies, despite the potential life-saving benefits they offer. Read More

CAR T-Cell Therapy for Glioblastoma

1 report the outcomes of treating three patients with a secreting chimeric antigen receptor (CAR) T cell (see Key Concepts). CAR T-cell technology has reshaped our therapeutic approach to ... Read More

Mustang Bio & City of Hope: CAR-T Cell Therapy Extends Treatment Refractory Glioblastoma Survival

Half the individuals receiving the new CAR-T cell therapy achieved stable disease or better. Intratumoral, intraventricular, and intratumoral + intraventricular administration routes all were ... Read More

Gene Therapy News

Genetic Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer ... therapy, according to the lead ... Researchers Identify Key Characteristics Associated With Improved CAR ... Read More

CAR T Cell Therapies Last Longer, Work Better with FOXO1 Protein

However, other studies showed that patients who were cured by CAR T therapy had cells that were more durable and able to fight the cancer longer ... Perelman School of Medicine and senior author ... Read More

Global CAR-T Cell Therapy Market Expected to Surge to USD 34.04 Billion by 2034 with a CAGR of 23.33%

Experts anticipate substantial growth in the CAR-T cell therapy sector, with forecasts suggesting a reach ... cancer treatment, CAR-T cell therapies stand at the forefront of personalized medicine ... Read More

Study reveals inequities in access to CAR T cell therapy

CAR T cell therapy is a personalized form of cancer therapy that was pioneered at Penn Medicine and has brought ... like this becomes available, it reaches all patients who might be able to ... Read More